A patient with advanced liver disease presents with jaundice, ascites, and elevated serum ammonia levels. The patient is currently on lactulose therapy to manage hepatic encephalopathy. Which nursing intervention is most important to evaluate the effectiveness of the lactulose therapy?

B) Monitor the patient's bowel movement frequency and consistency.

A) Measure the patient's abdominal girth daily.

B) Monitor the patient's bowel movement frequency and consistency.

C) Assess the patient's skin turgor and mucous membranes.

D) Check the patient's blood pressure and heart rate regularly.

A patient with worsening liver function is being treated for ascites, hepatic encephalopathy, and portal hypertension. Which intervention should the nurse prioritize to effectively manage the patient's hepatic encephalopathy?

B) Administer lactulose as prescribed to reduce ammonia levels

A) Monitor daily weight to assess fluid accumulation

B) Administer lactulose as prescribed to reduce ammonia levels

C) Educate the patient on a low-protein diet to decrease ammonia production

D) Initiate diuretic therapy to manage ascites and reduce edema

A patient with liver disease and ascites has been diagnosed with spontaneous bacterial peritonitis (SBP). Following the initiation of a broad-spectrum intravenous antibiotic, the patient exhibits hypotension and tachycardia. As the nurse, what is the most appropriate intervention to address the patient's hemodynamic instability?

B) Increase the rate of intravenous fluid resuscitation.

A) Administer a vasopressor to increase blood pressure.

B) Increase the rate of intravenous fluid resuscitation.

C) Prepare for intubation due to decreased oxygen saturation.

D) Administer a diuretic to manage fluid overload.

A patient with liver disease and ascites has developed spontaneous bacterial peritonitis (SBP) and is being treated with intravenous antibiotics. The patient's blood pressure is 95/60 mmHg, heart rate is 110 beats per minute, respiratory rate is 24 breaths per minute, and oxygen saturation is 92% on room air. What is the nurse's priority intervention in managing this patient?

B) Initiate aggressive intravenous fluid resuscitation to address potential hypovolemia.

A) Administer supplemental oxygen to improve oxygen saturation.

B) Initiate aggressive intravenous fluid resuscitation to address potential hypovolemia.

C) Increase the dose of lactulose to enhance ammonia elimination.

D) Prepare the patient for an immediate CT scan of the abdomen to assess for other complications.

A patient with liver disease is experiencing increasing leukocytosis, renal impairment, and electrolyte imbalances despite ongoing treatment. Which of the following nursing interventions should be prioritized to address the current clinical concerns and prevent further deterioration?

C) Administer albumin infusion cautiously to support intravascular volume.

A) Increase the dose of lactulose to manage encephalopathy.

B) Initiate a low-sodium diet to control hyponatremia.

C) Administer albumin infusion cautiously to support intravascular volume.

D) Withhold antibiotics until culture sensitivity results are available.

A patient with liver disease is experiencing worsening renal function and signs of infection despite broad-spectrum antibiotics and fluid resuscitation. Which nursing intervention should be prioritized to address the patient's current condition?

C) Administer albumin infusions as prescribed to support intravascular volume.

A) Increase the rate of IV fluids to improve blood pressure and renal perfusion.

B) Monitor the patient's abdominal girth and weight daily to assess for worsening ascites.

C) Administer albumin infusions as prescribed to support intravascular volume.

D) Discontinue lactulose therapy to prevent further electrolyte imbalance.

A patient with advanced liver disease is experiencing moderate ascites and signs of portal hypertension. Culture sensitivity results have identified Escherichia coli as the causative organism for their infection, and the team has decided to initiate albumin infusions. Which nursing intervention is most appropriate to monitor the effectiveness of albumin therapy in this patient?

D) Evaluate urine output and monitor blood pressure trends

A) Measure daily abdominal girth and monitor for changes

B) Monitor peripheral edema and skin turgor

C) Assess for signs of dyspnea and auscultate lung sounds

D) Evaluate urine output and monitor blood pressure trends

A patient with advanced liver disease and moderate ascites is being managed with diuretics and albumin infusions. Recent culture sensitivity results indicate an Escherichia coli infection. Given these findings, which of the following nursing interventions is most appropriate to prioritize in the management of this patient?

B) Administer the targeted antibiotic therapy as prescribed and monitor for signs of infection resolution.

A) Increase the frequency of abdominal girth measurements to monitor ascites progression.

B) Administer the targeted antibiotic therapy as prescribed and monitor for signs of infection resolution.

C) Educate the patient on the importance of sodium restriction to prevent further fluid accumulation.

D) Collaborate with the healthcare team to adjust diuretic dosage based on daily weight changes and electrolyte levels.

A patient with advanced liver disease presents with increasing respiratory distress, mild confusion, and elevated ammonia levels. Which nursing intervention should be prioritized to address the patient's altered mental status?

A) Administer lactulose to decrease ammonia levels.

B) Provide supplemental oxygen to improve oxygenation.

C) Prepare the patient for a therapeutic thoracentesis.

D) Adjust the diuretic regimen to manage ascites.

A patient with advanced liver disease presents with increasing respiratory distress, confusion, and elevated ammonia levels. Which nursing intervention should be prioritized to address the patient's altered mental status?

B) Initiate lactulose therapy to decrease ammonia levels

A) Administer supplemental oxygen to improve oxygen saturation

B) Initiate lactulose therapy to decrease ammonia levels

C) Perform a therapeutic thoracentesis to relieve pleural effusion

D) Adjust diuretic regimen to manage ascites

liver disease - Nursing Case Study

Pathophysiology

• Primary mechanism: Hepatocyte injury and inflammation lead to fibrosis. Damaged liver cells trigger an immune response, causing inflammation and scar tissue formation, which disrupts liver architecture and functionality.

• Secondary mechanism: Portal hypertension occurs as fibrosis obstructs blood flow through the liver. This increased pressure in the portal vein system leads to complications like varices and ascites, significantly affecting patient outcomes.

• Key complication: Impaired liver function reduces detoxification and synthesis of essential proteins, leading to metabolic imbalances, coagulopathy, and encephalopathy, which are critical nursing concerns requiring close monitoring and intervention.

Patient Profile

Demographics:

52-year-old male, accountant

History:

• Key past medical history: Hypertension, Type 2 Diabetes, Alcohol use disorder

• Current medications: Metformin, Lisinopril, Atorvastatin

• Allergies: Penicillin

Current Presentation:

• Chief complaint: Abdominal pain and fatigue

• Key symptoms: Jaundice, nausea, decreased appetite, swelling in legs

• Vital signs: Blood pressure 150/90 mmHg, Heart rate 98 bpm, Respiratory rate 18 breaths per minute, Temperature 99.1°F, Oxygen saturation 94% on room air

Section 1

During the initial assessment, the nurse notes several significant findings that suggest worsening liver function and possible complications. The patient's skin and sclerae are markedly jaundiced, and there is noticeable asterixis, indicating potential hepatic encephalopathy. The abdominal examination reveals a distended abdomen with a positive fluid wave test, suggestive of ascites. Palpation demonstrates hepatomegaly and tenderness in the right upper quadrant, consistent with liver inflammation. The patient's lower extremities exhibit pitting edema, more pronounced than previously documented, likely due to hypoalbuminemia and portal hypertension.

Laboratory results confirm the clinical assessment. Liver function tests reveal elevated bilirubin levels at 5.8 mg/dL, with significantly increased AST and ALT levels, indicating ongoing hepatocellular injury. The patient's albumin level is low at 2.5 g/dL, and the INR is elevated at 1.8, reflecting impaired liver synthetic function and coagulopathy. Additionally, serum ammonia levels are elevated at 85 µmol/L, correlating with the patient's mental status changes and risk of hepatic encephalopathy. These findings necessitate immediate clinical interventions and further diagnostic imaging to evaluate the extent of portal hypertension and potential variceal development.

Given these assessments, the healthcare team initiates interventions to address the complications. Diuretic therapy is prescribed to manage ascites and reduce peripheral edema, while lactulose is started to decrease ammonia levels and mitigate encephalopathy risk. The patient is educated about the importance of adhering to a low-sodium diet to help control fluid retention. A referral to a hepatologist is made for further evaluation, including the potential need for endoscopic surveillance of varices. This comprehensive approach aims to stabilize the patient's condition and prevent further deterioration, while close monitoring of vital signs and laboratory parameters guides ongoing treatment adjustments.

Section 2

As the healthcare team closely monitors the patient's response to interventions, new complications arise that necessitate further clinical evaluation and decision-making. Over the next 48 hours, the patient exhibits a gradual improvement in mental status, attributed to the initiation of lactulose therapy. However, vital signs reveal a concerning trend: the patient's blood pressure has dropped to 95/60 mmHg, and the heart rate has increased to 110 beats per minute, suggestive of possible hypovolemia or the development of a secondary complication. Furthermore, the patient's respiratory rate has increased to 24 breaths per minute, and oxygen saturation has decreased slightly to 92% on room air, prompting further investigation into potential respiratory implications or evolving complications.

Given the new hemodynamic changes, the healthcare team considers the possibility of spontaneous bacterial peritonitis (SBP), a common and serious complication in patients with ascites. The team orders a diagnostic paracentesis to analyze the ascitic fluid for cell count and culture. The results reveal an elevated white blood cell count in the ascitic fluid with a predominance of neutrophils, confirming the diagnosis of SBP. Immediate initiation of broad-spectrum intravenous antibiotics is crucial to prevent further deterioration and sepsis.

In light of these developments, the patient's management plan is adjusted to include aggressive intravenous fluid resuscitation, along with continuous monitoring of renal function and electrolytes, given the potential risk of hepatorenal syndrome. The interdisciplinary team collaborates to reassess the patient's condition and modify the treatment regimen to stabilize hemodynamic status while addressing the underlying infection. This scenario highlights the need for ongoing vigilance and adaptability in managing complex liver disease, with the goal of preventing further complications and optimizing the patient's recovery trajectory.

Section 3

Over the next 24 hours, the healthcare team closely monitors the patient's response to the administered interventions. Despite the initiation of broad-spectrum intravenous antibiotics and fluid resuscitation, new diagnostic results reveal a troubling trend in the patient's laboratory values. The latest complete blood count shows an increasing leukocytosis with a white blood cell count rising to 17,000/mm³, indicative of ongoing or worsening infection. Additionally, the patient's renal function tests reveal a serum creatinine level of 2.1 mg/dL, up from 1.2 mg/dL, raising concerns about the onset of acute kidney injury, potentially linked to hepatorenal syndrome. Electrolyte panels also show mild hyponatremia, with serum sodium decreasing to 130 mEq/L. These findings necessitate a re-evaluation of the current management strategy, emphasizing the need for enhanced renal protection and more targeted infection control measures.

The patient's change in status is further evidenced by subtle yet significant shifts in clinical presentation. Although mental status continues to gradually improve with lactulose therapy, the patient reports increased abdominal discomfort and exhibits mild abdominal distension, suggesting the possibility of worsening ascites or inadequate response to diuretic therapy. The vital signs remain concerning, with persistent tachycardia at 112 beats per minute and hypotension at 92/58 mmHg, despite aggressive fluid management. The respiratory rate is steady at 24 breaths per minute, but the patient now requires supplemental oxygen to maintain an oxygen saturation of 94%, pointing to potential respiratory compromise or fluid overload.

In response to these developments, the healthcare team prioritizes a thorough reassessment of fluid management strategies, considering the cautious use of albumin infusions to support intravascular volume without exacerbating ascites. The team also deliberates the potential need for nephrology consultation to address the renal implications and adjust the antibiotic regimen based on culture sensitivity results. This evolving clinical scenario underscores the importance of dynamic clinical reasoning and coordinated care to navigate the complexities of liver disease with coexisting systemic complications, aiming to stabilize the patient and prevent further deterioration.

Section 4

As the healthcare team continues to navigate the complexities of the patient's condition, new diagnostic results shed further light on the evolving clinical picture. A repeat abdominal ultrasound reveals moderate ascites, confirming the suspicion of fluid accumulation in the abdominal cavity. This finding, coupled with the patient's report of increased abdominal discomfort and distension, suggests that the current diuretic therapy may be inadequate. The ultrasound also shows signs of splenomegaly, which is often associated with portal hypertension, a common complication of liver disease.

The team's attention turns to the latest culture sensitivity results, which identify Escherichia coli as the causative organism of the infection. This necessitates a shift in the antibiotic regimen to a more targeted therapy, potentially enhancing infection control efforts. Concurrently, the decision is made to initiate albumin infusions with a cautious approach, aiming to improve circulatory stability without exacerbating the ascites or overloading the renal system. The patient's renal function remains a concern, with creatinine levels holding steady but elevated, suggesting the need for ongoing nephrology input to optimize renal protective strategies.

These developments prompt a re-evaluation of the patient's overall management plan, emphasizing the critical balance between addressing systemic infections, supporting liver function, and preventing renal deterioration. The team remains vigilant in monitoring the patient's hemodynamic status and renal function closely, recognizing the interconnected nature of these systems in the context of advanced liver disease. The next steps involve careful titration of diuretics, ongoing assessment of fluid balance, and frequent monitoring of laboratory values to guide further interventions, aiming to stabilize the patient and improve clinical outcomes.

Section 5

As the patient progresses through treatment, a change in their clinical status becomes apparent, warranting immediate attention from the healthcare team. Over the past 24 hours, the patient has developed increasing respiratory distress, characterized by a respiratory rate of 28 breaths per minute and an oxygen saturation level that has dropped to 89% on room air. Auscultation reveals diminished breath sounds in the lower lung fields, suggesting possible pleural effusion, which could be secondary to the worsening ascites. The patient also exhibits mild confusion, a concerning sign that may indicate hepatic encephalopathy, a common complication in advanced liver disease.

The latest laboratory results reveal a further decline in liver function, with serum bilirubin levels rising to 4.5 mg/dL and an INR of 2.1, indicating significant coagulopathy. Additionally, ammonia levels are elevated at 78 µmol/L, correlating with the observed mental status changes. Renal function tests show a slight increase in creatinine to 2.1 mg/dL, underscoring the precarious balance between fluid management and renal perfusion.

In response to these developments, the healthcare team prioritizes stabilizing the patient's respiratory status and addressing the potential hepatic encephalopathy. Supplemental oxygen therapy is initiated to improve oxygenation, and a therapeutic thoracentesis is considered to alleviate the suspected pleural effusion. Lactulose is administered to reduce ammonia levels, with careful monitoring for any adverse gastrointestinal effects. The team also deliberates on adjusting the diuretic regimen to better manage the ascites while ensuring renal protection. These interventions are carefully evaluated to prevent further complications, emphasizing the importance of a coordinated and dynamic approach in managing this complex case.